Elan D Louis1. 1. Department of Neurology, College of Physicians and Surgeons, Mailman School of Public Health, Columbia University, New York, NY, USA. EDL2@columbia.edu
Abstract
BACKGROUND: Essential tremor (ET) is among the most prevalent neurological diseases. Age of onset, a key variable in neuroepidemiological and genetic research, is chiefly assessed by self-report rather than medical record review; the latter may be of little use. As a researcher, one wonders about the quality of this self-report. Is age of onset something which can be reproducibly self-reported by patients? There are few published data to aid researchers. METHODS: Age of onset was self-reported at two time points (baseline and follow-up) in 86 ET cases in a longitudinal epidemiological study in New York. RESULTS: The mean follow-up interval was 5.7 ± 2.5 (maximum = 14) years. Overall, agreement between the baseline and follow-up reports was high (ρ = 0.85, p < 0.001). Yet the difference (age of onset (baseline) - age of onset (follow-up)) ranged widely (from -47 to 32 years), and in one fifth of cases was ≥ 10 years. Greater agreement was associated with several clinical factors including age, medication use, embarrassment, depressive symptoms, cognitive test score and disease duration. CONCLUSIONS: Differences in reported age of onset in ET may vary widely, and in up to one fifth of patients may be substantial. Investigators should approach these self-reports with caution.
BACKGROUND: Essential tremor (ET) is among the most prevalent neurological diseases. Age of onset, a key variable in neuroepidemiological and genetic research, is chiefly assessed by self-report rather than medical record review; the latter may be of little use. As a researcher, one wonders about the quality of this self-report. Is age of onset something which can be reproducibly self-reported by patients? There are few published data to aid researchers. METHODS: Age of onset was self-reported at two time points (baseline and follow-up) in 86 ET cases in a longitudinal epidemiological study in New York. RESULTS: The mean follow-up interval was 5.7 ± 2.5 (maximum = 14) years. Overall, agreement between the baseline and follow-up reports was high (ρ = 0.85, p < 0.001). Yet the difference (age of onset (baseline) - age of onset (follow-up)) ranged widely (from -47 to 32 years), and in one fifth of cases was ≥ 10 years. Greater agreement was associated with several clinical factors including age, medication use, embarrassment, depressive symptoms, cognitive test score and disease duration. CONCLUSIONS: Differences in reported age of onset in ET may vary widely, and in up to one fifth of patients may be substantial. Investigators should approach these self-reports with caution.
Authors: M I Kamboh; M M Barmada; F Y Demirci; R L Minster; M M Carrasquillo; V S Pankratz; S G Younkin; A J Saykin; R A Sweet; E Feingold; S T DeKosky; O L Lopez Journal: Mol Psychiatry Date: 2011-10-18 Impact factor: 15.992
Authors: Carson R Reider; Cheryl A Halter; Peter F Castelluccio; David Oakes; William C Nichols; Tatiana Foroud Journal: Mov Disord Date: 2003-03 Impact factor: 10.338
Authors: Sheng-Han Kuo; Jie Wang; William J Tate; Ming-Kai Pan; Geoffrey C Kelly; Jesus Gutierrez; Etty P Cortes; Jean-Paul G Vonsattel; Elan D Louis; Phyllis L Faust Journal: Cerebellum Date: 2017-04 Impact factor: 3.847